Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed or Refractory Follicular Lymphoma

NCT05338879 · clinicaltrials.gov ↗

COMPLETED

Status

247

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Follicular Lymphoma

Interventions

OTHER: Non-Interventional

Sponsor

Regeneron Pharmaceuticals